Urology · Northridge, CA
NPI
1578577664
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
18350 Roscoe Blvd, Suite 701
Northridge, CA, 91325
Phone (818) 885-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$507K
15,923 services
Medicare patients, 2024
872
Average age 75
Drug cost, 2024
$770K
3,398 prescriptions
Company payments, 2025
$483
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elise S Perer was code J0585 (injection, onabotulinumtoxina, 1 unit), 4,300 times for 18 patients. In total Elise S Perer billed 15,923 services in 71 codes, and Medicare paid $507K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-12-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 4,300 | 18 | $4.99 | $21K |
| 99213 Office E&M - Established | Office | 1,662 | 676 | $77.27 | $128K |
| 81003 Clinical Chemistry | Office | 1,503 | 676 | $2.19 | $3,288 |
| 51798 Ultrasound - Nonspecific | Office | 1,007 | 519 | $10.48 | $11K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 608 | 407 | $100.16 | $61K |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 517 | 352 | $98.79 | $51K |
| 99214 Office E&M - Established | Office | 373 | 261 | $105.79 | $39K |
| 99232 Hospital E&M - Subsequent | Facility | 340 | 73 | $70.23 | $24K |
| 64566 Musculoskeletal | Office | 290 | 34 | $109.23 | $32K |
| 99211 Office E&M - Established | Office | 285 | 127 | $21.25 | $6,058 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 163 | 29 | $0.35 | $57.05 |
| 84153 Clinical Chemistry | Office | 140 | 93 | $18.02 | $2,523 |
| 51702 Other Organ Systems | Office | 133 | 24 | $58.58 | $7,791 |
| 99204 Office E&M - New | Office | 118 | 118 | $135.27 | $16K |
| 51705 Other Organ Systems | Office | 91 | 13 | $83.92 | $7,636 |
By year: 2022 $425K for 12,421 services; 2023 $495K for 14,455 services; 2024 $507K for 15,923 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,503 | 676 | $2.19 | $3,288 |
| 84153 Clinical Chemistry | 140 | 93 | $18.02 | $2,523 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 23 | 23 | $18.92 | $435 |
Medicare prescription drug claims, 2024
In 2024, the drug Elise S Perer prescribed most often to Medicare patients was Myrbetriq (Mirabegron), with 529 prescriptions and refills. In total Elise S Perer wrote 3,398 Medicare prescriptions that cost $770K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | 529 | 1,055 | 161 | $466K |
| Tamsulosin Hcl Generic | 480 | 1,156 | 134 | $6,919 |
| Solifenacin Succinate Generic | 381 | 948 | 124 | $27K |
| Estradiol Generic | 306 | 618 | 140 | $18K |
| Cephalexin Generic | 198 | 261 | 127 | $1,650 |
| Finasteride Generic | 188 | 493 | 58 | $2,728 |
| Fosfomycin Tromethamine Generic | 175 | 198 | 81 | $25K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 172 | 200 | 98 | $1,260 |
| Gemtesa Vibegron | 138 | 315 | 52 | $151K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 107 | 295 | 42 | $4,852 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 91 | 91 | 59 | $1,042 |
| Ciprofloxacin Hcl Generic | 91 | 91 | 68 | $381 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 51 | 57 | 38 | $197 |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 45 | 104 | 11 | $5,759 |
| Potassium Citrate Er Potassium Citrate | 45 | 63 | Under 11 | $3,603 |
Brand drugs: - claims; generic drugs: 2,655 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elise S Perer $483 ($483 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $268.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.